Ixazomib As Consolidation and Maintenance Versus Observation in Patients with Relapsed Multiple Myeloma Eligible for Salvage Autologous Stem-Cell Transplantation (myeloma XII [accord]): Interim Analysis of a Multicentre, Open-Label, Randomised, Phase 3 Trial
The Lancet Haematology(2024)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要